|
1
|
Fock KM: Review article: The epidemiology
and prevention of gastric cancer. Aliment Pharmacol Ther.
40:250–260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maehara Y, Orita H, Okuyama T, Moriguchi
S, Tsujitani S, Korenaga D and Sugimachi K: Predictors of lymph
node metastasis in early gastric cancer. Br J Surg. 79:245–247.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ohtsu A: Current status and future
prospects of chemotherapy for metastatic gastric cancer: A review.
Gastric Cancer. 8:95–102. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gaspar MJ, Arribas I, Coca MC and
Diez-Alonso M: Prognostic value of carcinoembryonic antigen, CA
19-9 and CA 72-4 in gastric carcinoma. Tumour Biol. 22:318–322.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tennent GA, Brennan SO, Stangou AJ,
O'Grady J, Hawkins PN and Pepys MB: Human plasma fibrinogen is
synthesized in the liver. Blood. 109:1971–1974. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weisel JW: Fibrinogen and fibrin. Adv
Protein Chem. 70:247–299. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamashita H, Kitayama J, Kanno N, Yatomi Y
and Nagawa H: Hyperfibrinogenemia is associated with lymphatic as
well as hematogenous metastasis and worse clinical outcome in T2
gastric cancer. BMC Cancer. 6:1472006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takeuchi H, Ikeuchi S, Kitagawa Y, Shimada
A, Oishi T, Isobe Y, Kubochi K, Kitajima M and Matsumoto S:
Pretreatment plasma fibrinogen level correlates with tumor
progression and metastasis in patients with squamous cell carcinoma
of the esophagus. J Gastroenterol Hepatol. 22:2222–2227. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Son HJ, Park JW, Chang HJ, Kim DY, Kim BC,
Kim SY, Park SC, Choi HS and Oh JH: Preoperative plasma
hyperfibrinogenemia is predictive of poor prognosis in patients
with nonmetastatic colon cancer. Ann Surg Oncol. 20:2908–2913.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vesely MD and Schreiber RD: Cancer
immunoediting: Antigens, mechanisms, and implications to cancer
immunotherapy. Ann NY Acad Sci. 1284:1–5. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guthrie GJ, Charles KA, Roxburgh CS,
Horgan PG, McMillan DC and Clarke SJ: The systemic
inflammation-based neutrophil-lymphocyte ratio: Experience in
patients with cancer. Crit Rev Oncol Hematol. 88:218–230. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shimada H, Takiguchi N, Kainuma O, Soda H,
Ikeda A, Cho A, Miyazaki A, Gunji H, Yamamoto H and Nagata M: High
preoperative neutrophil-lymphocyte ratio predicts poor survival in
patients with gastric cancer. Gastric Cancer. 13:170–176. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sharaiha RZ, Halazun KJ, Mirza F, Port JL,
Lee PC, Neugut AI, Altorki NK and Abrams JA: Elevated preoperative
neutrophil:lymphocyte ratio as a predictor of postoperative disease
recurrence in esophageal cancer. Ann Surg Oncol. 18:3362–3369.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mano Y, Shirabe K, Yamashita Y, Harimoto
N, Tsujita E, Takeishi K, Aishima S, Ikegami T, Yoshizumi T,
Yamanaka T and Maehara Y: Preoperative neutrophil-to-lymphocyte
ratio is a predictor of survival after hepatectomy for
hepatocellular carcinoma: A retrospective analysis. Ann Surg.
258:301–305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li MX, Liu XM, Zhang XF, Zhang JF, Wang
WL, Zhu Y, Dong J, Cheng JW, Liu ZW, Ma L and Lv Y: Prognostic role
of neutrophil-to-lymphocyte ratio in colorectal cancer: A
systematic review and meta-analysis. Int J Cancer. 134:2403–2413.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: American Joint Committee on Cancer (AJCC)
Cancer Staging Manual (7th). New York, NY: Springer. 117–121.
2010.
|
|
18
|
Hirashima K, Watanabe M, Shigaki H,
Imamura Y, Ida S, Iwatsuki M, Ishimoto T, Iwagami S, Baba Y and
Baba H: Prognostic significance of the modified Glasgow prognostic
score in elderly patients with gastric cancer. J Gastroenterol.
49:1040–1046. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamaguchi T, Yamamoto Y, Yokota S,
Nakagawa M, Ito M and Ogura T: Involvement of interleukin-6 in the
elevation of plasma fibrinogen levels in lung cancer patients. Jpn
J Clin Oncol. 28:740–744. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sahni A, Simpson-Haidaris PJ, Sahni SK,
Vaday GG and Francis CW: Fibrinogen synthesized by cancer cells
augments the proliferative effect of fibroblast growth factor-2
(FGF-2). J Thromb Haemost. 6:176–183. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sahni A and Francis CW: Vascular
endothelial growth factor binds to fibrinogen and fibrin and
stimulates endothelial cell proliferation. Blood. 96:3772–3778.
2000.PubMed/NCBI
|
|
22
|
Fridman WH, Galon J, Dieu-Nosjean MC,
Cremer I, Fisson S, Damotte D, Pagès F, Tartour E and
Sautès-Fridman C: Immune infiltration in human cancer: prognostic
significance and disease control. Curr Top Microbiol Immunol.
344:1–24. 2011.PubMed/NCBI
|
|
23
|
Arigami T, Uenosono Y, Ishigami S,
Matsushita D, Hirahara T, Yanagita S, Okumura H, Uchikado Y, Nakajo
A, Kijima Y and Natsugoe S: Decreased density of CD3+
tumor-infiltrating lymphocytes during gastric cancer progression. J
Gastroenterol Hepatol. 29:1435–1441. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao JJ, Pan K, Wang W, Chen JG, Wu YH, Lv
L, Li JJ, Chen YB, Wang DD, Pan QZ, et al: The prognostic value of
tumor-infiltrating neutrophils in gastric adenocarcinoma after
resection. PLoS One. 7:e336552012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Satomi A, Murakami S, Ishida K, Mastuki M,
Hashimoto T and Sonoda M: Significance of increased neutrophils in
patients with advanced colorectal cancer. Acta Oncol. 34:69–73.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sato H, Tsubosa Y and Kawano T:
Correlation between the pretherapeutic neutrophil to lymphocyte
ratio and the pathologic response to neoadjuvant chemotherapy in
patients with advanced esophageal cancer. World J Surg. 36:617–622.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lorente D, Mateo J, Templeton AJ,
Zafeiriou Z, Bianchini D, Ferraldeschi R, Bahl A, Shen L, Su Z,
Sartor O and de Bono JS: Baseline neutrophil-lymphocyte ratio (NLR)
is associated with survival and response to treatment with
second-line chemotherapy for advanced prostate cancer independent
of baseline steroid use. Ann Oncol. 26:750–755. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sim SH, Kim YJ, Oh DY, Lee SH, Kim DW,
Kang WJ, Im SA, Kim TY, Kim WH, Heo DS and Bang YJ: The role of
PET/CT in detection of gastric cancer recurrence. BMC Cancer.
9:732009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
McMillan DC: The systemic
inflammation-based Glasgow Prognostic Score: A decade of experience
in patients with cancer. Cancer Treat Rev. 39:534–540. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vashist YK, Loos J, Dedow J, Tachezy M,
Uzunoglu G, Kutup A, Yekebas EF and Izbicki JR: Glasgow Prognostic
Score is a predictor of perioperative and long-term outcome in
patients with only surgically treated esophageal cancer. Ann Surg
Oncol. 18:1130–1138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lamb GW, Aitchison M, Ramsey S, Housley SL
and McMillan DC: Clinical utility of the Glasgow Prognostic Score
in patients undergoing curative nephrectomy for renal clear cell
cancer: Basis of new prognostic scoring systems. Br J Cancer.
106:279–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
